10/12/2024 CervoMed’s experimental drug fails to meet its endpoints in Phase II study for dementia with Lewy bodies Science watch
09/12/2024 Vivoryon Therapeutics announces topline Phase II VIVA-MIND study results in early AD Science watch
04/12/2024 Empowering Alzheimer’s caregivers with conversational AI: a novel approach for enhanced communication and personalized support Science watch
01/12/2024 A recent study suggests that maternal immune activity is associated with the offspring’s long-term brain health Science watch
26/11/2024 Anavex Life Sciences submits a marketing authorisation approval for Alzheimer’s drug blarcamesine to the EMA Science watch
22/11/2024 Assessing Aβ status before disease-modifying therapies: Findings from a 10-year real-world study Science watch
14/11/2024 Alzheimer Europe welcomes the positive European Medicines Agency opinion on lecanemab Science watch
14/11/2024 Systematic review of decision-making processes for pain assessment and management for people living with dementia is published online Science watch
